Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

Assessing relapses and response to relapse treatment in patients with multiple sclerosis: a nursing perspective.

Ross AP, Halper J, Harris CJ.

Int J MS Care. 2012 Fall;14(3):148-59. doi: 10.7224/1537-2073-14.3.148.

2.

Updates on clinically isolated syndrome and diagnostic criteria for multiple sclerosis.

Marcus JF, Waubant EL.

Neurohospitalist. 2013 Apr;3(2):65-80. doi: 10.1177/1941874412457183.

3.

Multiple sclerosis, relapses, and the mechanism of action of adrenocorticotropic hormone.

Ross AP, Ben-Zacharia A, Harris C, Smrtka J.

Front Neurol. 2013 Mar 8;4:21. doi: 10.3389/fneur.2013.00021.

4.

Expert recommendations to personalization of medical approaches in treatment of multiple sclerosis: an overview of family planning and pregnancy.

Borisow N, Döring A, Pfueller CF, Paul F, Dörr J, Hellwig K.

EPMA J. 2012 Jun 22;3(1):9. doi: 10.1186/1878-5085-3-9.

5.

Potential immunological consequences of pharmacological suppression of gastric acid production in patients with multiple sclerosis.

Biswas S, Benedict SH, Lynch SG, LeVine SM.

BMC Med. 2012 Jun 7;10:57. doi: 10.1186/1741-7015-10-57. Review.

6.

Deferiprone modulates in vitro responses by peripheral blood T cells from control and relapsing-remitting multiple sclerosis subjects.

Sweeney ME, Slusser JG, Lynch SG, Benedict SH, Garcia SL, Rues L, LeVine SM.

Int Immunopharmacol. 2011 Nov;11(11):1796-801. doi: 10.1016/j.intimp.2011.07.007.

Supplemental Content

Support Center